Professor of Medicine (Oncology), Stanford University
Douglas W. Blayney, M.D. is the Principal Investigator for Study 105 and Study 106.
Dr. Blayney is a Professor of Medicine (Oncology) at Stanford University and former Medical Director of Stanford Cancer Center. He is a founding member and former board member of the NCCN Guidelines for neutropenia management in US, former president of the American Society of Clinical Oncology (ASCO) and has served on the Food and Drug Administration's Oncologic Drugs Advisory Committee.
© 2020 BeyondSpring Inc. All rights reserved.